| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 15,562 | 17,579 | 14,324 | 18,150 | | Cost of Revenue | 12,763 | 7,119 | 6,585 | 7,619 | | | Gross Profit | 2,799 | 10,460 | 7,739 | 10,531 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,302 | 8,743 | 8,784 | 13,093 | | Non Recurring |
-
|
-
|
-
| (3,279) | | Others | 1,349 | 1,354 | 1,355 | 1,267 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 148 | 363 | (2,400) | (550) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 42,003 | 74 | 114 | 248 | | Earnings Before Interest And Taxes | 42,151 | 437 | (2,286) | (302) | | Interest Expense | 718 | 718 | 716 | 737 | | Income Before Tax | 41,433 | (281) | (3,002) | (1,039) | | Income Tax Expense | 962 | (172) | (790) | (731) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 40,471 | (109) | (2,212) | (308) | | | Non-recurring Events | | Discontinued Operations | (13,092) |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 27,379 | (109) | (2,212) | (308) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $27,379 | ($109) | ($2,212) | ($308) |
|
0.02% Nasdaq 
Income Statement
